Phase II trial of DNA methyltransferase 1 inhibition with the antisense oligonucleotide MG98 in patients with metastatic renal carcinoma: A National Cancer Institute of Canada Clinical Trials Group investigational new drug study

By Winquist Eric   Knox Jennifer   Ayoub Jean-Pierre   Wood Lori   Wainman Nancy   Reid Gregory   Pearce Laura   Shah Ajit   Eisenhauer Elizabeth  

Investigational New Drugs, Vol. 24, Iss. 2, 2006-03 ,pp. : 159-167

Springer Publishing Company

Access to resources Recommend Favorite

Influence of mtDNA genetic variation on antibiotic therapy

By Pacheu-Grau David   Gómez-Durán Aurora   Montoya Julio   Ruiz-Pesini Eduardo  

Pharmacogenomics, Vol. 11, Iss. 9, 2010-09 ,pp. : 1185-1187

Future Medicine

Access to resources Recommend Favorite

Production of Non Viral DNA Vectors

By  

Current Gene Therapy, Vol. 10, Iss. 6, 2010-12 ,pp. : 487-507

Bentham Science Publishers

Access to resources Recommend Favorite

Application of Genetic Polymorphisms in DNA Repair in the Prediction of Cancer Susceptibility and Clinical Outcome

By  

Current Pharmacogenomics, Vol. 1, Iss. 3, 2003-09 ,pp. : 175-186

Bentham Science Publishers

Access to resources Recommend Favorite

Use of DNA Microarrays to Monitor Host Response to Virus and Virus-Derived Gene Therapy Vectors

By Stefania Piersanti   Yuri Martina   Gioia Cherubini   Daniele Avitabile   Isabella Saggio  

American Journal of PharmacoGenomics, Vol. 4, Iss. 6, 2004-01 ,pp. : 345-356

Adis International

Access to resources Recommend Favorite